<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: To explore the anti-inflammatory mechanism of Diammonium <z:chebi fb="0" ids="29807">Glycyrrhizinate</z:chebi> in a rat model of <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> induced by <z:chebi fb="22" ids="15366">acetic acid</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Spragur-Dawley female rats were divided into four groups: Diammonium <z:chebi fb="0" ids="29807">Glycyrrhizinate</z:chebi> group, <z:chebi fb="0" ids="41879">dexamethasone</z:chebi> group, <z:chebi fb="22" ids="15366">acetic acid</z:chebi> control and <z:mpath ids='MPATH_458'>normal</z:mpath> control group </plain></SENT>
<SENT sid="2" pm="."><plain>Colonic <z:mp ids='MP_0001845'>inflammation</z:mp> was evaluated by disease activity index, gross morphologic damage, histological injury and colonic myeloperoxidase activity </plain></SENT>
<SENT sid="3" pm="."><plain>Immunohistochemistry was used to detect the expression of NF-kappaB, TNF-alpha and ICAM-1 in colonic mucosa </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Compared to the <z:chebi fb="22" ids="15366">acetic acid</z:chebi> control, both Diammonium <z:chebi fb="0" ids="29807">Glycyrrhizinate</z:chebi> and <z:chebi fb="0" ids="41879">dexamethasone</z:chebi> showed a significant anti-inflammatory effect (P &lt; 0.01) </plain></SENT>
<SENT sid="5" pm="."><plain>The expression of NF-kappaB, TNF-alpha and ICAM-1 in colonic mucosa was significantly lower in the Diammonium <z:chebi fb="0" ids="29807">Glycyrrhizinate</z:chebi> group and <z:chebi fb="0" ids="41879">dexamethasone</z:chebi> group than in the <z:chebi fb="22" ids="15366">acetic acid</z:chebi> group </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSION: Diammonium <z:chebi fb="0" ids="29807">Glycyrrhizinate</z:chebi> could reduce inflammatory injury in a rat model of <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>This may occur via suppression of NF-kappaB, TNF-alpha and ICAM-1 in colonic mucosa </plain></SENT>
</text></document>